CLDN8 anticorps (C-Term)
-
- Antigène Voir toutes CLDN8 Anticorps
- CLDN8 (Claudin 8 (CLDN8))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLDN8 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)
- Specificité
- Claudin 8 Antibody detects endogenous levels of total Claudin 8.
- Homologie
- Bovine,Horse,Sheep,Rabbit
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogène
- A synthesized peptide derived from human Claudin 8, corresponding to a region within C-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product CLDN8 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:1000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
- Date de péremption
- 12 months
-
- Antigène
- CLDN8 (Claudin 8 (CLDN8))
- Autre désignation
- CLDN8 (CLDN8 Produits)
- Synonymes
- anticorps zgc:91900, anticorps wu:fa01e05, anticorps CLDN8, anticorps AI648025, anticorps claudin 8, anticorps CLDN8, anticorps cldn8, anticorps Cldn8
- Sujet
-
Description: Tight-junction protein required for paracellular chloride transport in the kidney. Mediates recruitment of CLDN4 to tight junction in the kidney. Claudins play a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.
Gene: CLDN8
- Poids moléculaire
- 28 kDa
- ID gène
- 9073
- UniProt
- P56748
- Pathways
- Hepatitis C
-